Human Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) and p16 Expression in Squamous Cell Carcinoma of the Head and Neck. [PDF]
Calaisselvane U +3 more
europepmc +1 more source
HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer
ABSTRACT Human papillomavirus (HPV) is a well‐established prognostic factor in head and neck (HN) cancer, with HPV‐positive patients exhibiting markedly better survival outcomes compared to their HPV‐negative counterparts. While advances in (cancer) genomics have been pivotal to precision medicine, existing gene screening methods for identifying ...
Atika Farzana Urmi +2 more
wiley +1 more source
The prevalence, nature and trajectory of oropharyngeal dysphagia within the first year following curative open resection for esophageal cancer. [PDF]
Hayes M +5 more
europepmc +1 more source
Congenital Oropharyngeal Teratoma: A Rare Cause of Respiratory and Feeding Difficulties. [PDF]
Tuijl F +4 more
europepmc +1 more source
Isolated dysphagia masking myasthenia gravis diagnosis. [PDF]
Lusvarghi IL +5 more
europepmc +1 more source
Symptom Clusters and Related Factors of Late Toxicities in Head and Neck Cancer Survivors After Radiation Therapy: A Cross-Sectional Study. [PDF]
Genka T, Kamizato M.
europepmc +1 more source
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. [PDF]
Rumgay H +12 more
europepmc +1 more source
Endoscopic-assisted low-temperature plasma resection of tongue root schwannoma via oral approach: a case report and literature review. [PDF]
He J, Cai X, Feng H, Bao Y, Qin G.
europepmc +1 more source
Related searches:
This study analyses the incidence of second neoplasms in patients with oropharyngeal carcinoma according to human papillomavirus (HPV) status and its impact on survival.A retrospective analysis of 583 patients with oropharyngeal cancer treated between 1991 and 2023 was performed.
Cristina Valero +2 more
exaly +3 more sources
The possibilities of accompanying therapy for malignant oropharyngeal neoplasms
P.A. Herzen Journal of Oncology, 2023Objective. To evaluate the efficiency of incorporating remaxol into the accompanying therapy regimen for patients with malignant oropharyngeal neoplasms with the manifestations of toxic reactions to etiotropic treatment. Subjects and methods. The data of 104 patients (88 men and 16 women) with R-negative oropharyngeal cancer (T3-4N0-3M0) were analyzed.
M.I. Ivanova +5 more
openaire +1 more source

